The European Commission has approved Keytruda as a monotherapy for the first-line treatment of adult patients with metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer.
The National Comprehensive Cancer Network issued a guidance for COVID-19 vaccinations in people with cancer.
A nationwide panel of experts has developed the first mammography guidelines for older survivors of breast cancer, providing a framework for discussions between survivors and their physicians on the pros and cons of screening in survivors' later years.
A study published in Cancer Causes & Control demonstrates that four in 10 cancer deaths are attributable to cigarette smoking in parts of the South region and Appalachia. For the study, Farhad Islami and colleagues at the American Cancer Society examined the proportion of cancer deaths from 2013 to 2017 attributed to cigarette smoking in […]
Our nation's NCI-designated comprehensive cancer centers are charged with developing and leading cutting-edge research to reduce the nation's cancer burden.
Older minority cancer patients with poor social determinants of health are significantly more likely to experience negative surgical outcomes compared to white patients with similar risk factors, according to a study published by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC […]
Craig Lockhart was named chief of the Division of Hematology and Oncology in the Department of Medicine at the Medical University of South Carolina and associate director for clinical science at MUSC Hollings Cancer Center, effective April 1.
Terence M. Williams was named professor and chair of City of Hope's Department of Radiation Oncology.
Coalition of cancer organizations urges resumption of cancer screening and treatment during pandemic
The National Comprehensive Cancer Network and the American Cancer Society are teaming up with cancer organizations across the country to endorse the resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.
Cancer scientists from the Wellcome Sanger Institute, the Human Technopole in Milan, and the Broad Institute of MIT and Harvard are calling on cancer researchers to join a global initiative to systematically evaluate the effect of every genetic mutation and every drug on every cancer.
